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1. Introduction 
Although cyclic AMP was discovered in studies 
of the mode of action of glucagon in promoting liver 
glycogenolysis (see [l] ), the entire sequence of events 
initiated by the cyclic nucleotide is less well known in 
liver than in muscle. Indeed, in this tissue, as has 
been worked out very well by Krebs and co-workers 
(see [2] ) cyclic AMP brings about a sequential activa- 
tion of protein kinase, phosphorylase kinase and 
glycogen phosphorylase, leading ultimately to an 
enhanced rate of glycogen breakdown. In liver, the 
activation of glycogen phosphorylase by glucagon also 
involves a rise in the cyclic AMP content (see [ 11) and 
an activation of protein kinase [3,4] but up till now, 
there has only been one report describing an enhanced 
activity of phosphorylase kinase [5]. 
In the present report, we show that glucagon does 
indeed cause a substantial increase in the liver phos- 
phorylase kinase activity; we show furthermore that 
this activation is caused by the action of the cyclic 
AMP dependent protein kinase. 
2. Materials and methods 
2.1. Materials 
Glucagon was obtained from Novo-laboratories 
(Copenhagen), collagenase type I, bacitracin, histone 
fZb, ATP and cyclic AMP from Sigma Chemical Co. 
(St. Louis), and glycogen from Merck A. G. (Darmstadt). 
[Y-~‘P] ATP was purchased from the Radiochemical 
Centre (Amersham). All other chemicals were of 
reagent grade. Crystalline rabbit muscle phosphorylase 
b, isolated according to [6], was a gift of Dr G. 
Defreyn. 
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Protein kinase inhibitor was isolated up to the 
TCA precipitation step, as described by Walsh et al. 
[7]. After dialysis against 5 mM potassium phosphate, 
1 mM EDTA, pH 7.0, the preparation was clarified by 
centrifugation at 34 000 g for 20 min [7] and made 
100 mM in NaF, 250 mM in sucrose and 5% in glycogen. 
2.2. Preparation and incubation of rat liver cells 
Liver cells were isolated essentially as described by 
Hue et al. [8] with the following modifications: the 
liver was perfused after its removal from the animal; a 
Krebs-Henseleit bicarbonate buffer at pH 7.4, gassed 
with 95% 02, 5% CO2 was used; the inital cell sus- 
pension was passed through a nylon filter (100 mesh). 
Before incubation, the cells were stored at 0°C in a 
large Erlenmeyer containing the OZ/COZ mixture. 
The incubation was started with 0.6 ml of a cell 
suspension in Krebs-Henseleit bicarbonate buffer 
(about 1 O7 cells/ml) containing bacitracin (1 mg/ml); 
the cells were incubated at 37°C in closed plastic 
20 ml vials with continuous shaking (120 oscillations/ 
min) in the presence of the O&O2 mixture. A 
preincubation of up to 45 min in the presence of 
20 mM glucose was routinely performed in order to 
bring phosphorylase a to a low level 181. After this 
preincubation, one or several aliquots of the cell 
suspension were frozen in tubes kept in liquid N,; 
IO-20 ~1 of the hormone solution were then added, 
the vial gassed again with the Oz/COZ mixture, 
stoppered and further incubated; at 1 min intervals, 
one or more aliquots were taken out and frozen, while 
the vial was each time gassed with OZ/COZ and closed. 
At the end of the incubation more than 85-90% of 
the cells excluded trypan blue; the frozen cells were 
kept at -20°C until they were processed for enzyme 
assays. 
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2.3. Enzyme assays 
For the assay of the endogenous liver phosphorylase 
a (EC 2.4.1.1) the frozen cells were thawed out by 
shaking them in 3 vol of an ice-cold 100 mM glycyl- 
glycine buffer, pH 7.4, containing 0.5% glycogen, 
100 mM NaF and 20 mM EDTA; liver phosphorylase 
a was measured as described in detail [8] except that 
temperature was raised to 25°C. It was checked that 
this method of homogenization yielded the same 
enzyme activities as those obtained with the con- 
ventional homogenization in a Potter-Elvehjem tube. 
For the assay of protein kinase (EC 2.7,1.37) the 
cells were thawed out by shaking them in 9 vol of 
an ice-cold medium, containing 250 mM sucrose, 
10 mM potassium phosphate buffer, pH 7.4,4 mM 
EDTA and 2 mM dithiotreitol. Protein kinase was 
assayed as described before [4] with histone f,, as 
the substrate. 
The amount of protein kinase inhibitor required to 
abolish completely the protein kinase activity (as 
assayed with 10e6 M cyclic AMP) was determined and 
was then used in those experiments where it was 
decided to block protein kinase activity. The protein 
kinase inhibitor preparation had no effect on the 
phosphorylase kinase activity. 
For the assay of phosphorylase kinase (EC 2.7.1.38) 
the cells were thawed out directly in 4 vol of the 
protein kinase inhibitor preparation. For some 
experiments, where preincubation with the endogenous 
protein kinase was desirable, the same phosphate buffer 
containing EDTA, NaF, sucrose and glycogen (see 
under 2.1.) was used without protein kinase inhibitor. 
In standard phosphorylase kinase assays, 50 ~1 of the 
thawed out cell suspension were mixed with 100 ~1 
of a solution containing 0.2 mg phosphorylase b, 
1 mM Tris pH 7.0 and, whenever necessary, protein 
kinase inhibitor. (The final concentration of the 
inhibitor in the assay of phosphorylase kinase was the 
same whether it was added in the thawing of the cells 
or only in the phosphorylase kinase assay). This 
mixture was then equilibrated at 30°C for 2 min after 
which the reaction was started by the addition of 
30 ~1 of an ATP-Mg acetate solution. The final con- 
centration of ATP and Mg was 0.3 mM and 1.5 mM 
respectively. To stop the phosphorylase kinase reac- 
tion, a 20 ~1 aliquot was withdrawn at various times 
of incubation and diluted with 0.2 ml of cold 10 mM 
/.?-glycerolphosphate buffer, pH 6.8, containing 40 mM 
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/3-mercaptoethanol and 20 mM NaF. 100 ~1 of these 
diluted samples were then used for the determination 
of phosphorylase a activity at 30°C [9]. One mU of 
phosphorylase kinase catalyzes the formation of 1 mU 
of phosphorylase a per min under these conditions. 
3. Results 
As shown in fig.1, ghrcagon (2 X low9 M) caused 
a rapid activation of the endogenous glycogen 
phosphorylase as previously observed with intact 
anaesthetized rats [4]. Since maximal activation is 
obtained within 1 min, in subsequent experiments 
cells stimulated by ghtcagon for 1 mm were used. 
Glucagon, known to activate liver protein kinase 
in vivo [3,4], also activated this enzyme in isolated 
liver cells (table 1). When assayed without added 
0 1 2 3 
Time after glucagon (mini 
Fig.1. Kinetics of the activation of liver glycogen phosphorylase 
by glucagon in isolated liver cells. Liver cells (1 O’/ml) were 
preincubated for 30-45 min with 20 mM glucose; phos- 
phorylase a level was measured in aliquots taken immediately 
before and at various time intervals after the addition of auca- 
gon (2 X 10e9 M). Results shown are the means of 10 
experiments ?: S.E.M. 
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Fig.2. Effect of glucagon on the activity of liver phosphorylase kinase. Liver cells (5 X 106/ml) were preincubated for 45 min with 
20 mM glucose; phosphorylase 6 kinase was assayed in samples taken immediately before and 1 min after the addition of 
2 x lO-9 M glucagon, which raised endogenous phosphorylase a from 15 to 65, and protein kinase from 0.1 to 0.2 mU/mg liver 
protein. (A) homogenization of the liver cells in the buffer containing the protein kinase inhibitor; (B) homogenization in buffer 
only; (C) homogenization as in (B) but protein kinase inhibitor present in the assay medium for phosphorylase kinase (see also 
under 2.3.). (0) Before and (0) after glucagon. 
cyclic AMP, the protein kinase activity of the 
glucagon (2 X 1 O-’ M) stimulated cells was twice 
that of the non stimulated cells. Higher concentrations 
of glucagon (1 0T6 M) caused a four- to five-fold 
increase (not shown). Total protein kinase activity, as 
measured in the presence of 1 0e6 M cyclic AMP, was 
not significantly affected. 
When the activity of the phosphorylase kinase was 
determined in the presence of the protein kinase 
inhibitor, a clearcut activation of this enzyme was 
observed after glucagon (fig.2A). However, when the 
protein kinase inhibitor was not included in the dilu- 
tion buffer to thaw out the liver cells, no difference 
was observed and the non-stimulated cells displayed 
now as much activity as the stimulated cells (fig.2B). 
About the same result was obtained when the cells 
were thawed out in the absence of the protein kinase 
inhibitor and then assayed for phosphorylase kinase 
in the presence of added inhibitor (fig.2C). 
The average values of phosphorylase kinase 
recorded before and after the glucagon stimulation 
are presented in table 1. A nearly 2-fold stimulation 
by glucagon was observed. We checked that the 
increase in phosphorylase a formation induced by 
the hormone was not due to an enhanced AMP 
production leading to an erroneous overestimation 
of phosphorylase a activity due to a stimulation of the 
exogenous phosphorylase b. 
4. Discussion 
The results presented here clearly indicate that 
the activation of glycogen phosphorylase by glucagon 
21.5 
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Table 1 
Effect of glucagon on liver glycogen phosphorylase, protein 
kinase and phosphorylase b kinase 
Enzyme CAMP Glucagon 
(mU/mg liver 
protein) 





15.4 + 1.4 61.2 f 2.0a 
- 0.15 f 0.02 0.33 f o.osa 
+ 0.78 f 0.05 0.79 f 0.05 
110 *3 194 f 7a 
Enzyme activities were measured in liver cells (5 X 106/ml) before and after 1 min 
stimulation by 2 X lo-’ M glucagon. The cells had been preincubated with 20 mM 
glucose for 45 min. It was verified that no activity changes occurred when 
glucagon was not added to the cells. Values shown are means (+- S.E.M.) for 6 
experiments. Statistical significance was calculated from paired data. 
aP<o.oos 
involves a substantial increase in the activity of liver 
phosphorylase kinase. This activation of phosphorylase 
kinase completes for the liver the cascade of kinase 
reactions leading to the formation of phosphorylase 
a as known to proceed in the.muscle. Glucagon 
initiates glycogenolysis in the liver by stimulating 
the adenyl cyclase; the increase in intracellular 
cyclic AMP activates the protein kinase resulting in 
the activation of the phosphorylase kinase responsible 
for the increased production of glycogen phosphory- 
lase a. 
It should be noted that when no precaution was 
taken to add the protein kinase inhibitor when 
thawing out the liver cells, the phosphorylase kinase 
activity was already high without the addition of 
glucagon and was not further increased by the 
hormone. Furthermore, high activities of phosphory- 
lase kinase were also recorded without hormonal 
stimulation.when the protein kinase inhibitor was 
included too late, i.e. in the assay mixture of phos- 
phorylase kinase, but after the cells had already been 
thawed out (fig.2). It seems therefore that the time 
it takes to thaw out the cell suspension is enough 
for protein kinase, even at O”C, to insure activation 
of the phosphorylase kinase. 
These results show that the liver phosphorylase 
kinase, as the muscle enzyme, can be activated under 
the action of protein kinase, presumably in a phos- 
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phorylation step. This early blocking of protein 
kinase by its inhibitor seems to be necessary to show 
a glucagon promoted activation of phosphorylase 
kinase under our working conditions. This may not 
be an absolute requirement when using other 
experimental conditions as has been reported by 
others [5]. 
We conclude that glucagon causes a substantial 
activation of the liver phosphorylase kinase and that 
this activation is catalyzed by the cyclic AMP 
dependent protein kinase. 
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